Arrhythmogenic right ventricular dysplasia: Difference between revisions

Line 16: Line 16:
*[[Syncope]] (26%)
*[[Syncope]] (26%)
*Ventricular dysrhythmia/[[cardiac arrest]] (23%)
*Ventricular dysrhythmia/[[cardiac arrest]] (23%)
**Especially occurring during exercise
*Family history of unexplained syncope or sudden death
*Family history of unexplained syncope or sudden death
*Dysrhythmias refractory to anti-dysrhythmic meds
*Dysrhythmias refractory to anti-dysrhythmic meds
Line 21: Line 22:
**Usually these patients are identified through genetic testing of an affected or symptomatic family member
**Usually these patients are identified through genetic testing of an affected or symptomatic family member
*Right ventricular failure (6%)
*Right ventricular failure (6%)
*Dilated cardiomyopathy
*[[Dyspnea]]
*[[Dyspnea]]
*Atypical [[chest pain]] (6%)
*Atypical [[chest pain]] (6%)

Revision as of 00:50, 20 March 2019

Background

  • Second most common cause of sudden cardiac death in young patients [1]
    • Up to 20% of sudden cardiac deaths in young people
  • Usually occurs in people of Greek or Italian descent
  • Male:Female = 3:1
  • 1:1000-10,000 in the US
  • Fibro-fatty replacement of right ventricular myocardium
  • Two forms:
    • Autosomal dominant
      • Variable penetrance
    • Autosomal recessive
      • Naxos disease (Palmoplantar keratoderma) [2]

Clinical Features

  • Palpitations (27%)
  • Syncope (26%)
  • Ventricular dysrhythmia/cardiac arrest (23%)
    • Especially occurring during exercise
  • Family history of unexplained syncope or sudden death
  • Dysrhythmias refractory to anti-dysrhythmic meds
  • Asymptomatic (40%)
    • Usually these patients are identified through genetic testing of an affected or symptomatic family member
  • Right ventricular failure (6%)
  • Dilated cardiomyopathy
  • Dyspnea
  • Atypical chest pain (6%)

Differential Diagnosis

Cardiomyopathy

Syncope Causes

T Wave Inversions

Evaluation

ECG

ARVD.png

  • Epsilon wave (30-50%): positive deflection at the end of the QRS complex
  • V1-V3 TWI (especially in patients >14 yrs old) (85%)
  • V1-V3 QRS widening
  • Sudden VT episodes with a LBBB morphology
  • Prolonged S-wave upstroke of 55 ms in V1-3 (95%)

Imaging

Major and minor criteria rely on echo and cardiac MRI

  • Echo - hypokinetic and dilated RV, dilation of RVOT
  • Cardiac MRI - fibro-fatty change with RV myocardial thinning, RV aneurysms, RV dilatation

Management

  • Sotalol is the preferred anti-dysrhythmic
  • Manage heart failure in the usual manner

Disposition

  • Symptomatic presentation: Admission to cardiology
  • Incidental finding: Cardiology follow-up for further risk assessment and possible ICD placement or ablation

References

  1. https://litfl.com/arrhythmogenic-right-ventricular-cardiomyopathy-arvc/
  2. Protonotarios, N., and Tsatsopoulou, A. (2006). Naxos disease: Cardiocutaneous syndrome due to cell adhesion defect. Orphanet Journal of Rare Diseases, 1(4).
  • Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician. 2006 Apr 15;73(8):1391-8.
  • Perez Diez D, Brugada J. Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia. E-Journal of the ESC Council for Cardiology Practice, European Society of Cardiology 2008.